Treatment of Disseminated Gonococcal Infection in Arthritis and Arthritis-Dermatitis Syndrome
Disseminated gonococcal infection (DGI) presenting as arthritis or the arthritis-dermatitis syndrome requires a specific, structured antibiotic approach — one that differs from the management of uncomplicated gonococcal infection and follows defined criteria for both initiation and modification of therapy.
Clinical Scenario
This protocol addresses DGI in patients with arthritis or the arthritis-dermatitis syndrome as the primary manifestation. These presentations indicate haematogenous spread and are managed with a duration-defined antibiotic course that includes clear guidance on when and how therapy may be adjusted.
Treatment Approach
Management follows an evidence-based antibiotic regimen. The protocol specifies criteria for transitioning therapy once early clinical improvement is established and susceptibility data are available. The complete regimen, step-down options, and decision points are detailed in the full structured protocol.
Treatment Goal
The primary clinical target is improvement of symptoms within 24–48 hours after starting treatment.
References
DOI: 10.1177/09564624251345195
- Ceftriaxone 1 g IM or IV every 24 h (GRADE 1D).
- For arthritis and arthritis-dermatitis syndrome, therapy should continue for 7 days but may be switched 24–48 h after symptoms improve to oral cefixime 800 mg twice daily or ciprofloxacin 500 mg twice daily if the isolate is susceptible (note warning above for fluoroquinolones).